Free Trial

Koninklijke Philips (PHG) Competitors

$26.30
+0.03 (+0.11%)
(As of 06/7/2024 ET)

PHG vs. HOLX, CHEK, CI, HCA, GSK, BMY, ZTS, GILD, MCK, and BDX

Should you be buying Koninklijke Philips stock or one of its competitors? The main competitors of Koninklijke Philips include Hologic (HOLX), Check-Cap (CHEK), The Cigna Group (CI), HCA Healthcare (HCA), GSK (GSK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Gilead Sciences (GILD), McKesson (MCK), and Becton, Dickinson and Company (BDX). These companies are all part of the "medical" sector.

Koninklijke Philips vs.

Hologic (NASDAQ:HOLX) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

94.7% of Hologic shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 1.8% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hologic has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.03B4.31$456M$1.9638.02
Koninklijke Philips$19.66B1.21-$503.27M-$0.96-27.40

Hologic presently has a consensus price target of $85.60, suggesting a potential upside of 14.88%. Given Koninklijke Philips' stronger consensus rating and higher probable upside, research analysts clearly believe Hologic is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
Koninklijke Philips
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Hologic received 482 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.76% of users gave Hologic an outperform vote while only 56.75% of users gave Koninklijke Philips an outperform vote.

CompanyUnderperformOutperform
HologicOutperform Votes
856
69.76%
Underperform Votes
371
30.24%
Koninklijke PhilipsOutperform Votes
374
56.75%
Underperform Votes
285
43.25%

Hologic has a net margin of 11.78% compared to Hologic's net margin of -4.41%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic11.78% 18.91% 10.44%
Koninklijke Philips -4.41%9.82%4.04%

Hologic has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Koninklijke Philips has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

In the previous week, Hologic had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 10 mentions for Hologic and 3 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.42 beat Hologic's score of 1.11 indicating that Hologic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hologic beats Koninklijke Philips on 17 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PHG vs. The Competition

MetricKoninklijke PhilipsX IndustryMedical SectorNYSE Exchange
Market Cap$23.84B$14.83B$5.22B$17.71B
Dividend Yield3.48%1.82%2.73%3.54%
P/E Ratio-27.4022.32119.8023.59
Price / Sales1.2112.902,424.4514.37
Price / Cash9.1011.8435.1620.21
Price / Book1.832.444.964.99
Net Income-$503.27M$217.56M$110.48M$975.94M
7 Day Performance-3.10%-5.35%-1.08%-1.87%
1 Month Performance1.15%-7.31%-0.67%-0.74%
1 Year Performance34.63%-21.53%2.88%8.66%

Koninklijke Philips Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOLX
Hologic
4.8386 of 5 stars
$74.20
-0.6%
$85.60
+15.4%
-5.5%$17.32B$4.03B37.866,990Analyst Revision
Positive News
CHEK
Check-Cap
0 of 5 stars
$2.27
flat
N/A-7.4%$13.28MN/A-0.7685Upcoming Earnings
CI
The Cigna Group
4.9429 of 5 stars
$330.03
-2.1%
$373.87
+13.3%
+29.1%$93.75B$195.27B27.1072,500Ex-Dividend
HCA
HCA Healthcare
4.6424 of 5 stars
$334.23
+0.7%
$325.59
-2.6%
+23.4%$87.54B$64.97B16.66310,000Analyst Upgrade
Positive News
GSK
GSK
2.5776 of 5 stars
$41.93
+1.4%
$47.00
+12.1%
+19.9%$86.90B$37.71B15.1970,200Gap Up
BMY
Bristol-Myers Squibb
4.9331 of 5 stars
$41.19
-1.3%
$60.00
+45.7%
-36.3%$83.50B$45.01B-13.2934,100
ZTS
Zoetis
4.7271 of 5 stars
$176.09
+2.4%
$211.75
+20.3%
+8.1%$80.35B$8.54B33.9314,100
GILD
Gilead Sciences
4.9625 of 5 stars
$64.04
-0.2%
$83.69
+30.7%
-15.0%$79.78B$27.12B177.8918,000Analyst Revision
MCK
McKesson
4.3436 of 5 stars
$576.50
+0.5%
$571.47
-0.9%
+52.6%$74.94B$308.95B25.7651,000Analyst Downgrade
Insider Selling
BDX
Becton, Dickinson and Company
4.8181 of 5 stars
$236.31
-0.9%
$280.17
+18.6%
-4.6%$68.30B$19.37B52.0573,000Analyst Upgrade

Related Companies and Tools

This page (NYSE:PHG) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners